Measurement of the Radiation Dose Cuticles Using Electron Paramagnetic Resonance (EPR)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00904189|
Recruitment Status : Terminated (PI has relocated)
First Posted : May 19, 2009
Results First Posted : October 19, 2015
Last Update Posted : October 19, 2015
|Condition or disease||Intervention/treatment|
|Irradiation; Adverse Effect||Radiation: Standard of care given for treatment of cancer|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||2 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Measurement of the Radiation Dose Cuticles Using Electron Paramagnetic Resonance (EPR) Spectroscopy|
|Study Start Date :||November 2007|
|Primary Completion Date :||January 2008|
|Study Completion Date :||January 2008|
No Intervention: Standard of care radiation therapy
Standard of care given for treatment of cancer. Subjects receiving incidental radiation dose to fingernails.
Radiation: Standard of care given for treatment of cancer
Subjects receiving a known dose of radiation during Total Body Irradiation.
- Mean Dose of Radiation Received by Fingernails [ Time Frame: 2.5 years ]The mean dose in gray of radiation exposure to participants fingernails as determined by Electron Paramagnetic Resonance (EPR).
- Determination of the Range of Background Signal Measured by the EPR Device. [ Time Frame: 2.5 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00904189
|United States, New York|
|Department of Radiation Oncology, University of Rochester Medical Center|
|Rochester, New York, United States, 14642|
|Principal Investigator:||Steven Swarts, PhD||Department of Radiation Oncology, University of Rochester Medical Center|